Jaana Rautava1, Stina Syrjänen. 1. Department of Oral Pathology and Oral Radiology, Institute of Dentistry, Faculty of Medicine, University of Turku, Finland.
Abstract
BACKGROUND: Public awareness of human papillomavirus (HPV) as the causal agent of cervical cancer and of the availability of HPV vaccines has increased. As a result, more patients are asking their dentists about oral HPV infection and its prevention by means of vaccination. Parents of pediatric dental patients also may be concerned when their children have HPV-associated oral lesions, because HPV infection still often is considered a purely sexually transmitted disease. In this review, the authors provide the latest information for dental professionals about HPV infection in the oral mucosa and in general. TYPES OF STUDIES REVIEWED: The authors searched PubMed for all studies regarding HPV infection in the oral mucosa, and they reviewed relevant publications focusing exclusively on HPV infections of the oral cavity. In selecting studies for review, the authors made a clear distinction between studies regarding HPV infections in the mouth and those regarding HPV infection in the oropharynx or in other head and neck sites. RESULTS: HPV can infect oral mucosa. A subgroup of oral cancer clearly is associated with HPV. Oral HPV infection is transmitted sexually but also can be transmitted from mouth to mouth and vertically from an infected mother during delivery. CONCLUSIONS AND CLINICAL IMPLICATIONS: Persistent HPV infection in the oral mucosa might increase the risk of developing oral cancer. Regular and meticulous clinical examination is the dentist's most important tool in detecting HPV-associated changes in the oral mucosae. HPV-associated oral cancer may affect a population younger than that typically affected by HPV-independent oral cancer. Alcohol and tobacco use increase the risk of developing oral cancer, so good practice includes encouraging patients to avoid these habits. The available HPV vaccines cover the HPV genotypes found most commonly in the oral mucosa, but their protective effect against oral cancer remains to be elucidated.
BACKGROUND: Public awareness of human papillomavirus (HPV) as the causal agent of cervical cancer and of the availability of HPV vaccines has increased. As a result, more patients are asking their dentists about oral HPV infection and its prevention by means of vaccination. Parents of pediatric dental patients also may be concerned when their children have HPV-associated oral lesions, because HPV infection still often is considered a purely sexually transmitted disease. In this review, the authors provide the latest information for dental professionals about HPV infection in the oral mucosa and in general. TYPES OF STUDIES REVIEWED: The authors searched PubMed for all studies regarding HPV infection in the oral mucosa, and they reviewed relevant publications focusing exclusively on HPV infections of the oral cavity. In selecting studies for review, the authors made a clear distinction between studies regarding HPV infections in the mouth and those regarding HPV infection in the oropharynx or in other head and neck sites. RESULTS:HPV can infect oral mucosa. A subgroup of oral cancer clearly is associated with HPV. Oral HPV infection is transmitted sexually but also can be transmitted from mouth to mouth and vertically from an infected mother during delivery. CONCLUSIONS AND CLINICAL IMPLICATIONS: Persistent HPV infection in the oral mucosa might increase the risk of developing oral cancer. Regular and meticulous clinical examination is the dentist's most important tool in detecting HPV-associated changes in the oral mucosae. HPV-associated oral cancer may affect a population younger than that typically affected by HPV-independent oral cancer. Alcohol and tobacco use increase the risk of developing oral cancer, so good practice includes encouraging patients to avoid these habits. The available HPV vaccines cover the HPV genotypes found most commonly in the oral mucosa, but their protective effect against oral cancer remains to be elucidated.
Authors: E Daley; V Dodd; R DeBate; C Vamos; C Wheldon; N Kline; S Smith; R Chandler; K Dyer; H Helmy; A Driscoll Journal: Public Health Date: 2014-03-03 Impact factor: 2.427
Authors: Mayara Sabrina A Rodrigues; Raquel Silva Nascimento; Ricardo Roberto S Fonseca; Gláucia C Silva-Oliveira; Luiz Fernando A Machado; Emil Kupek; Benedikt Fischer; Aldemir B Oliveira-Filho Journal: Clin Oral Investig Date: 2020-11-22 Impact factor: 3.573
Authors: Katia Muller; Julie Kazimiroff; Mahnaz Fatahzadeh; Richard V Smith; Mauricio Wiltz; Jacqueline Polanco; Robert M Grossberg; Thomas J Belbin; Howard D Strickler; Robert D Burk; Nicolas F Schlecht Journal: J Infect Dis Date: 2015-02-13 Impact factor: 5.226
Authors: Robbie Woods; Esther M O'Regan; Susan Kennedy; Cara Martin; John J O'Leary; Conrad Timon Journal: World J Clin Cases Date: 2014-06-16 Impact factor: 1.337
Authors: Liesl K Jeffers; Kaiwen Duan; Lesley G Ellies; William T Seaman; Raquel A Burger-Calderon; Luda B Diatchenko; Jennifer Webster-Cyriaque Journal: J Cancer Ther Date: 2013-05